FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Track all the latest updates and news of Ajooni Biotech IPO.
April 23, 2024 7:30:15 PM
Biotech IPOs surged at the start of 2024, but the rest of the year will depend on Fed rate cuts. Meanwhile, doctors using VR and AI to hone their skills.
Published by : CNBC on MSNApril 26, 2024 7:31:00 PM
Sunho Biologics has no revenue or licensing income to draw on, making a loss of 133 million yuan last year as all its products remain at the R&D or clinical stage ...
Published by : Benzinga.comApril 5, 2024 10:30:00 AM
Contineum Therapeutics has lowered its IPO expectations as the Johnson & Johnson-partnered biotech prepares to make the jump to the public markets this morning Friday, April 5. The San Diego-based ...
Published by : FierceBiotechMarch 15, 2024 9:37:00 AM
While there may be exceptions and individual stock performances can vary widely, the first-day trading behavior of IPOs often provides insight into the long-term prospects of the biotech sector.
Published by : The UBJ on MSNApril 12, 2024 7:14:00 PM
Proceeds from biotech IPOs during the first three months of 2024 matched levels seen in the first quarters of 2019 and 2020, BioPharma Dive data shows.
Published by : BioPharma DiveMarch 29, 2024 3:30:00 AM
It has shown the same promise among people with general obesity. The San Diego-based biotech is close to completing a pre-IPO financing round in which it will raise between $75mn and $100mn from a ...
Published by : The Financial TimesMarch 28, 2024 10:40:00 AM
Boundless Bio is bringing in $100 million from its IPO as the precision oncology company becomes the latest biotech to go public in 2024. The company has priced its 6.25 million shares at $16 ...
Published by : FierceBiotechApril 4, 2024 3:30:00 AM
Contineum�s offering keeps biotech IPOs on their strongest pace in three years, according to BioPharma Dive data. By this time last year, only four drug startups had gone public, raising $375 ...
Published by : Yahoo FinanceMarch 30, 2024 9:30:00 AM
Three IPOs and one SPAC debuted this past week, while three IPOs submitted initial filings - Boundless Bio, U-BX Technology, Alta Global, and IB Acquisition, respectively. Three IPOs submitted ...
Published by : Seeking AlphaMarch 21, 2024 6:34:00 PM
Laura Chico, Senior VP at Wedbush, is optimistic about 2024 biotech IPO market and M&A trends. As the U.S. heads into an election year, the biotech sector often faces uncertainty that can impact ...
Published by : Benzinga.comApril 12, 2024 10:33:00 AM
The sum is more than three times the $375 million in total proceeds from biotech IPOs in the first quarter last year, and roughly matches the first quarter total in 2020. Six of the nine biotechs ...
Published by : Yahoo FinanceApril 10, 2024 11:07:00 AM
It�ll begin trading on the Nasdaq stock exchange on Friday under the symbol �CTNM.� Contineum�s offering keeps biotech IPOs on their strongest pace in three years, according to BioPharma Dive data. By ...
Published by : Yahoo FinanzasThe issue of Ajooni Biotech Limited opens on Dec 20, 2017 and closes for subscription on Dec 22, 2017. The equity shares of the company to be list at NSE SME. The price band for the issue has been fixed at Rs 30.
Ajooni Biotech Limited is entering in the capital market with an IPO of 21,96,000 Equity Shares of Rs 10 aggregating up to Rs. 6.59 Crore. The price band for the issue has been fixed at Rs 30 Per Equity Share.
Incorporated in 2010, Ajooni Biotech Limited is Mohali, Punjab based company engaged in manufacturing, producing, processing and supplying of Cattle feed, Nutrients related to cattle feed and manufacturing & production of Animal health care supplements.
The issue opens on Dec 20, 2017 and closes for subscription on Dec 22, 2017. The equity shares of the company to be list at NSE SME platform.
The Ajooni Biotech IPO is proposed to open on December 20, 2017. The IPO application ends on December 22, 2017.
Retail investors can apply in the retail or non-institutional investor category from December 20, 2017 to December 22, 2017. The Ajooni Biotech IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Ajooni Biotech IPO will open for subscription on December 20, 2017. The public issue will close on December 22, 2017.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|